Eli Lilly Other Non-Current Liabilities 2010-2024 | LLY

Eli Lilly other non-current liabilities for the quarter ending June 30, 2024 were $5.967B, a 12.96% increase year-over-year.

  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.
  • Eli Lilly other non-current liabilities for 2022 were $5.534B, a 0.55% decline from 2021.
  • Eli Lilly other non-current liabilities for 2021 were $5.564B, a 0.34% increase from 2020.

Eli Lilly Other Non-Current Liabilities 2010-2024 | LLY

  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.
  • Eli Lilly other non-current liabilities for 2022 were $5.534B, a 0.55% decline from 2021.
  • Eli Lilly other non-current liabilities for 2021 were $5.564B, a 0.34% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B